MURRIETA – Murrieta Genomics was recently named as a “company to watch” by The Healthcare Insights, a medical publication that discusses developments in medical technology and treatment for better global health in its July 2020 issue.
Murrieta Genomics was selected as “The Most Influential HealthTech Company to Watch in Genomics Solutions” vertical due to the valuable contributions the company is making in this niche.
“It is a great honor to be selected by The Healthcare Insights team,” Jay Goth, CEO of Murrieta Genomics. “We are a young company but making strides in impacting the genomic space by offering startups in this industry the sequencing and sector knowledge they need to develop their proof of concept. Our management team and advisory board is dedicated to launching the next great genomic companies.”
The print magazine reaches out to over 72,000 subscribers across the United States and Canada. The magazine’s mission is to help readers identify the companies that are bringing reliable and innovative solutions to the health care sector.
The July issue features the “20 Most Advanced Healthcare Tech Companies to Watch in 2020” that have pushed the envelope of the health care industry with their inspiring ideas and advanced health care solutions. Visit https://thehealthcareinsights.com/magazine/ to view the article.
The magazine contains thought-leadership articles and insights of health care experts, doctors, directors of research and development about the advancements in the health care sector over the past few years. Subscribers include chief information officers, chief technology officers, chief scientific officers, vice presidents for manufacturing, clinical research, clinical trials or drug discovery, head of clinical research and other technology buyers and leaders.
Murrieta Genomics provides access to next generation sequencing technology for researchers in the health, veterinary, agriculture, forensics and direct to consumer industries. The company is a true business incubator, offering mentorship and guidance from both the scientific and business perspective to aspiring genomic-related entrepreneurs. The founders of Murrieta Genomics have extensive background in business, finance, science and technology. They are supplemented with a prestigious advisory board from both business and science. The company provides Next Generation Sequencing services, hands-on consulting, review, appraisal and guidance. In addition, it provides help with company value propositions and potential seed funding support to qualified incubator graduates. For more information visit http://www.murrietagenomics.com.
Murrieta Genomics is part of the Murrieta Innovation Center, a RESI Tech Hub dedicated to supporting life science companies. The Innovation Center has medical device, therapeutic, software, clinical research and genomic companies that are working hard to advance new ideas and innovations that can impact the world in a positive way. The center is also a resource for all types of local startup companies, offering services and workshops from a local SBDC, several veteran organizations, a SCORE branch and more.
Submitted by city of Murrieta.